A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Eye & ENT Hospital of Fudan University
Medical University of South Carolina
Dana-Farber Cancer Institute
University of Miami
Alliance for Clinical Trials in Oncology
Fox Chase Cancer Center